EditorialMilitary veterans and veterans’ spouses during a group therapy session at a psychedelic retreat in Tijuana, Mexico, March 18, 2022. (Meridith Kohut/The New York Times)
EditorialMilitary veterans and veterans’ spouses during a group therapy session at a psychedelic retreat in Tijuana, Mexico, March 18, 2022. (Meridith Kohut/The New York Times)
EditorialNigel McCourry, a former Marine who took part in a clinical trial using the psychedelic drug MDMA, paired with therapy, to treat his PTSD, at his home in Portland, Ore., Feb. 21, 2022. (Amanda Lucier/The New York Times)
EditorialDr. Rick Roblin, holds the September 1985 issue of The Miami Herald magazine with himself on the cover, at his home in Belmont, Mass., Sept. 20, 2012. (Gretchen Ertl/The New York Times)
EditorialA dose of psilocybin in a ceremonial chalice at Johns Hopkins Bayview Medical Center in Baltimore, May 6, 2021. (Matt Roth/The New York Times)
EditorialScott Ostrom, who participated in a study of the drug MDMA, has suffered from PTSD since returning from Iraq in 2007. (Elliot Ross/The New York Times)